《血癌雜志》力求發(fā)表與血液學(xué)惡性腫瘤和相關(guān)疾病相關(guān)的高質(zhì)量文章。該雜志將考慮出版在該領(lǐng)域具有重大影響的原始研究、評(píng)論、指南和信件。特別感興趣的主題包括但不限于以下內(nèi)容：新化合物的臨床前研究，尤其是那些提供力學(xué)見解的化合物臨床試驗(yàn)和觀察血液學(xué)惡性腫瘤的新藥及治療進(jìn)展與新突變、分子途徑和腫瘤基因組學(xué)相關(guān)的新觀察《血癌雜志》提供了一個(gè)論壇，可以快速發(fā)表關(guān)于新突變或改變路徑的新觀察結(jié)果。

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field.Topics of particular interest include, but are not limited to, the following:Preclinical studies of new compounds, especially those that provide mechanistic insightsClinical trials and observationsReviews related to new drugs and current management of hematologic malignanciesNovel observations related to new mutations, molecular pathways, and tumor genomicsBlood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.